Bantam has a unique opportunity to provide meaningful benefits to cancer patients with significant unmet needs.
We are seeking partners and investors to join us as we progress our lead candidate BTM-3566 into clinical trials, expand into new indications and discover additional novel drugs.
Get in touch to learn more and speak with one of our team.
Get in touch